Stock Based Compensation (Tables)

Stock compensation expense for the three months ended December 31, 2017 and 2016 is as follows:

	Three Months Ended		Three Months Ended
Stock Compensation Expense	December 31, 2017		December 31, 2016
Stock grants	$	39,000	$	39,000
Restricted stock grants		13,000		13,000
Option grants		12,000		12,000
Employee stock purchase plan		1,000		1,000
Subsidiary option grants		28,000		24,000
Total	$	93,000	$	89,000

A summary of restricted stock activity for the three months ended December 31, 2017 is presented below:

Restricted Stock Activity for the Three Months ended December 31, 2017	Shares		Weighted-Average Grant-Date Fair Value
Nonvested at September 30, 2017		70,000	$	1.73

Granted		-
Vested		(10,000)	$	1.70
Cancelled		-		-
Nonvested and expected to vest at December 31, 2017		60,000	$	1.73

A summary of stock option activity for the three months ended December 31, 2017 is presented below:

	Options Outstanding		Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2017		196,769	$	1.98		1.64
Outstanding and exercisable at September 30, 2017		196,769	$	1.98		1.64
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at December 31, 2017		196,769	$	1.98		1.39
Outstanding and exercisable at December 31, 2017		196,769	$	1.98		1.39

A summary of Xcede stock option activity for the three months ended December 31, 2017 is presented below:

	Options Outstanding		Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2017		1,375,956	$	1.00		8.70
Outstanding and exercisable at September 30, 2017		923,617		1.00		8.30
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at December 31, 2017		1,375,956		1.00		8.44
Outstanding and exercisable at December 31, 2017		1,020,078	$	1.00		8.11